glp 1 agonist comparison Comparative efficacy and safety of GLP-1 receptor agonists for weight reduction: A model-based meta-analysis of placebo-controlled trials GLP-1 Agonist Comparison ๐
Description
doi:10.1038/s41598-021-86516-4 Liu T, Zhou L, Chen Y, Lin J, Zhu H
Int J Mol Med (2018) 41(5):297785
The role of GLP-1 receptor agonists in managing type 2 diabetes
Consider rapid sequence induction of anesthesia for intubation if retained gastric contents are present, using shared decision-making to weigh procedure cancellation vs
Wael Mctabi and Dr
In phase 3 trials, maximal dose retatrutide demonstrated 29% placebo-adjusted weight loss at 68 weeks (albeit with higher discontinuation rates than semaglutide and tirzepatide)
